Perennial Socially Responsive Shares Trust Monthly Report as at 31 May 2012
Perennial Socially Responsive Shares Trust*
Value Added (Detracted)
* Gross Performance. Past performance is not a reliable indicator of future performance.
• The largest positive performance contributor was HeartWare International Inc (up 8.4%).
• The Trust added to the existing position in QBE Insurance Group Limited (QBE) during the
• Chinese data released during the month suggested a slowing of some areas of the economy.
Trust Performance Overview Perennial Socially Responsive Shares
The Perennial Growth Socially Responsive Shares Trust (the Trust) finished down 7.3% in May, underperforming
the S&P/ASX300 Accumulation Index (the Index) return by
The Trust aims to provide a total return (after fees) that
0.6%, with the Index down 6.7% for the month.
exceeds the S&P/ASX 300 Accumulation Index
measured on a rolling three-year basis, by investing in
On current measures the valuation of a number of
a selection of listed companies which also embrace
domestic defensive stocks appear to be stretched. Stocks
and engender social performance in their corporate
such as Telstra Corporation Limited (Telstra) and
Woolworths Limited (Woolworths) are trading at a
Trust Manager: Risk Profile:
significant premium to our valuation target. Conversely,
the valuation upside to our current Trust based on
Trust FUM Income Distribution
valuation metrics is at elevated levels. Rarely has the
(as at 31/05/12): Frequency:
valuation gap between the Trust and the defensive areas
Minimum Initial
The largest positive performance contributor was
(as at 31/05/12): Investment:
HeartWare International Inc (up 8.4%). Following a
favourable vote last month regarding the safety of the
Trust Inception date: APIR code: IOF0117AU
company’s Ventricular Assist System (VAS) from the US
Food and Drug Administration Advisory Commission
(FDA), the company announced the publication of results
from ADVANCE, the company’s U.S. clinical trial
Mayne Pharma Group Limited (Mayne) (up 22.4%) also
evaluating the use of the HeartWare VAS as a bridge to
contributed positively. At the start of the month the
heart transplantation in patients with advanced heart
company announced that the US District Court for the
failure. The company is still awaiting full FDA approval for
District of New Jersey upheld the validity of the US patent
the device, but recent company announcements suggest
covering its Doryx 150mg product. While it also
that progress is being made towards achieving this. Given
determined that competitor generic versions of the drug
the stock is listed in both the US and Australia, the share
did not infringe the patent, it was still seen as a positive
price has also been a beneficiary of the appreciation of the
outcome for the company. Mayne also announced the
appointment of a new sales and marketing manager
during the month, who will have a focus on growing sales
Another positive performance contributor was BHP Billiton
Limited (not held, down 10.1%). The company
underperformed the market as a consequence of
The biggest detractor to performance during the month
concerns around the health of the global economy and the
was Sims Metal Management Limited (down 22.9%).
outlook for growth, with concerns around a slow down in
During the month, the company provided a trading update
China seeing commodity markets and resource stocks
which stated that earnings for FY12 will be materially less
than 85% of the prior corresponding period, including a
$36 million pre-tax gain on an asset sale. Global
Perennial Socially Responsive Shares Trust
competitor Schnitzer Steel also provided a trading update
Fortescue Metals Group Limited (down 18.1%) fell
which noted that global demand for scrap has remained
significantly further than the iron ore spot price (down
soft and a tepid US recovery and lower than normal spring
6.3%) during the month. At current levels we see
scrap flows have resulted in tighter supply and margins.
significant valuation upside to the stock price based on our
valuation metrics. We expect the company to achieve its
Challenger Limited (Challenger) (down 17.6%) also
55 million tons FY12 production target, and the plans to
underperformed. There have been a number of recurring
increase production to 155 million tons per annum remain
concerns expressed by investors, most of which, while not
on track with the company well capitalised to do this. We
completely resolved, look to be more than imputed into the
believe the stock is well over sold and took advantage of
current stock price. The areas of concern are largely
this weakness to add to the Trust’s position during the
related to capital and the potential need for a raising to
supplement current levels. Revised capital rules are set to
be finalised by Australian Prudential Regulation Authority
We also added to the position in PanAust Limited during
in October, with the new framework taking effect from 1
the month, following share price weakness.
January 2013. The areas of focus include the composition
of capital, asset charges under various stress scenarios,
We sold down the position in Carsales.com during the
the illiquidity premium relating to discounting future
month as the company’s share price approached our
liabilities and the transition arrangements for subordinated
valuation. The Trust trimmed positions in Heartware
debt. The sum of these impacts, after taking account of
International Inc, Sonic Healthcare Limited, OneSteel,
organic capital generation, leaves us feeling confident that
National Australia Bank and Seek Limited.
the transition to the new regime is manageable, with a low
probability of the need for a capital raising. With this in
At month end stock numbers stood at 36 with cash at
mind our fundamental assessment shows significant
Market Overview
Telstra (not held, up 0.3%) also detracted value. The stock
Macroeconomic factors once again dominated sentiment,
performed relatively well during May, as the company was
with no definitive outcome at the Greek political elections
seen as a safe haven given its predictable dividend yield
at the start of the month proving the catalyst for
over the next year. Over the past six months, it has
heightened concerns for the region’s economic
tracked the performance of government bonds closely as
sustainability, an elevated risk of a Greek exit from the
international investors, in particular, focused on the
European Union and increased government borrowing
company’s elevated dividend payout ratio.
costs in a number of European nations. Alongside this,
concerns of slowing economic growth in China and the US
Trust Activity
added to market woes. As a consequence equity markets
The Trust added to the existing position in QBE Insurance
fell sharply, with Hong Kong’s Hang Seng down 11.7%,
Group Limited (QBE) during the month, taking advantage
Japan’s Nikkei down 10.3%, UK’s FTSE100 down 7.3%,
of weakness to add to the position. There was no shortage
the US S&P500 down 6.3% and China’s Shanghai
of issues to drive the stock, with the regulator’s review on
Lenders Placed Insurance in New York the latest
challenge for the group. This represents 1% of QBE's
Chinese data released during the month suggested a
Lenders Placed business but does highlight some of the
slowing of some areas of the economy, with industrial
concerns around the pricing of such a cover. This is a
production falling to a three year low of 9.3% year on year
cyclical business and we expect that it will in time become
and a material reduction in both exports and imports
less of a driver of earnings. The more compelling news
pointing to slowing manufacturing activity. Despite this,
has been from fellow Property and Casualty insurers in
growth in China remains above the government’s 7.5%
the US. The commentary from many of these companies
per annum target, and the Chinese authorities have
on insurance rates has been consistently positive and in
shown themselves to be committed to providing the
necessary measures to stimulate the economy as
Investment Manager: Perennial Investment Partners Limited ABN 59 087 901 620, AFSL: 238763 (“Perennial”). Sub Managers: Perennial Value Management Limited, ABN 22 090 879 904, AFSL: 247293. Perennial Fixed Interest Partners Pty Limited ABN 35 099 336 357, Perennial Growth Management Pty Limited ABN 41 099 336 384 and Perennial Real Estate Investments Pty Limited ABN 35 117 913 685 are Subsidiaries and Authorised Representatives of Perennial. Responsible Entity: IOOF Investment Management Limited ABN 53 006 695 021, AFSL: 230524. This promotional statement is provided for information purposes only. Accordingly, reliance should not be placed on this promotional statement as the basis for making an investment, financial or other decision. This promotional statement does not take into account your investment objectives, particular needs or financial situation. Whilst every effort has been made to ensure the information in this promotional statement is accurate; its accuracy, reliability or completeness is not guaranteed. Past performance is not a reliable indicator of future performance. Gross performance does not include any applicable management fees or expenses. Net performance is based on redemption price for the period and assumes that all distributions are reinvested. Fees indicated reflect the maximum applicable. Contractual arrangements, including any applicable management fee, may be negotiated with certain large investors. Investments in the Trusts must be accompanied by the application form attached to the current product disclosure statement. The current product disclosure statement can be found on Perennial’s website www.perennial.net.au.
Perennial Socially Responsive Shares Trust
exemplified by recent reductions to the reserve Top Ten Holdings as at 31 May 2012 requirement, increased infrastructure spending and government subsidies for home appliances and autos. US
data showed revised economic growth at an annualised
rate of 1.9%. The unemployment rate fell slightly to 8.1%,
with nonfarm payrolls increasing by 115,000.
Domestically, the Reserve Bank of Australia took the decision to ease rates by 50 basis points, taking the cash
rate to 3.75%. This move further highlighted the
emergence of a two speed economy within Australia, with
the mining related component of the economy running at a growth level well in excess of the non-mining segments.
Despite this, employment data showed the economy add
15,500 new jobs in April with the unemployment rate
remaining at 5.2%. The Australian dollar weakened considerably against most major currencies closing the
Commodity markets also fell significantly during the month
with oil (down 14.7%), copper (down 11.6%), zinc (down
9.3%), nickel (down 9.3%), iron ore (down 7.3%) and
Asset Allocation as at 31 May 2012
aluminium (down 5.9%) all falling. Gold also fell to close at
Stock Name
As a consequence of the significant macroeconomic
impact on equity markets there was a wide dispersion in performance across the sectors. In the domestic equity
market the strongest performing stocks were those with
defensive characteristics and lower perceived earnings
variability. As a consequence the strongest performers were utilities (up 1.6%), telecommunications (up 0.2%)
and healthcare (down 0.5%). Stocks deemed to exhibit
cyclical exposures, particularly to energy or natural
resources, were dealt with harshly. The weakest performing sectors were materials (down 11.0%), energy
(down 10.2%) and industrials (down 8.4%).
Rounding accounts for small +/- from 100%.
Investment Manager: Perennial Investment Partners Limited ABN 59 087 901 620, AFSL: 238763 (“Perennial”). Sub Managers: Perennial Value Management Limited, ABN 22 090 879 904, AFSL: 247293. Perennial Fixed Interest Partners Pty Limited ABN 35 099 336 357, Perennial Growth Management Pty Limited ABN 41 099 336 384 and Perennial Real Estate Investments Pty Limited ABN 35 117 913 685 are Subsidiaries and Authorised Representatives of Perennial. Responsible Entity: IOOF Investment Management Limited ABN 53 006 695 021, AFSL: 230524. This promotional statement is provided for information purposes only. Accordingly, reliance should not be placed on this promotional statement as the basis for making an investment, financial or other decision. This promotional statement does not take into account your investment objectives, particular needs or financial situation. Whilst every effort has been made to ensure the information in this promotional statement is accurate; its accuracy, reliability or completeness is not guaranteed. Past performance is not a reliable indicator of future performance. Gross performance does not include any applicable management fees or expenses. Net performance is based on redemption price for the period and assumes that all distributions are reinvested. Fees indicated reflect the maximum applicable. Contractual arrangements, including any applicable management fee, may be negotiated with certain large investors. Investments in the Trusts must be accompanied by the application form attached to the current product disclosure statement. The current product disclosure statement can be found on Perennial’s website www.perennial.net.au.
AVALIAÇÃO DA QUALIDADE DOS ANTIBIÓTICOS GENÉRICOS, EXEMPLIFICADO ATRAVÉS DOS MEDICAMENTOS COM O PRINCÍPIO ATIVO: AMOXICILINA + CLAVULANATO DE POTÁSSIO João Lucena Neto Permanece, até os dias de hoje, em nossa população, o conceito de que os medicamentos mais caros são melhores e diversas causas têm contribuído para isso. Citamos uma: a classe médica que resiste a pr
Acta Orthop. Belg. , 2007, 73 , 795-798 Brucellar arthritis of the knee : A case report with delayed diagnosis From Universitair Ziekenhuis Brussel, Brussels, Belgium Brucellar septic arthritis has become extremely rare milk and infected milk products ( 7 ). It is a systemic in Western developed countries since bovine brucel- infectious disease with a broad spectrum of clinical